Developments in NDMM
|Developments in Newly Diagnosed Multiple Myeloma: Considerations for Improved Patient Outcomes|
CME, CPE, CNE
Sagar Lonial, MD, FACP and Saad Z. Usmani, MD, FACP
|Release Date: July 20, 2022|
Expiration Date: July 20, 2023
In this activity, two leading experts in multiple myeloma provide the latest updates in novel treatment regimens used in practice today and review emerging regimens currently in clinical trials for potential use in the future. They discuss how to currently approach treatment decisions for your patients with newly diagnosed multiple myeloma (NDMM) and strategies that may be incorporated into treatment to impact patient quality of life.
This activity was previously presented as a live webinar. Please note: If you participated in the live webinar, you are ineligible to receive an additional 1.0 contact hour of credit and may not re-submit for credit previously awarded.
Provided by MediCom Worldwide, Inc.
|Begin, Earn CreditView Only, No Credit|